Showing results (241-250 of 1,842) with videos related to
Sort By:
Pageof 185
Journal of Managed Care & Specialty Pharmacy|November 3, 2020
Budget impact analysis of darolutamide for treatment of nonmetastatic castration-resistant prostate cancerSreevalsa Appukkuttan, Ryan Farej, LaStella Miles, et al.Journal of Managed Care & Specialty Pharmacy|October 29, 2021
ICER report on Alzheimer's disease: implications from a patient perspectiveMeg FranklinJournal of Managed Care & Specialty Pharmacy|October 29, 2021
The effectiveness and value of aducanumab for Alzheimer's diseasePatricia G Synnott, Melanie D Whittington, Grace A Lin, et al.Journal of Managed Care & Specialty Pharmacy|October 29, 2021
Payer perceptions on the use of economic models in oncology decision makingJoseph Biskupiak, Gary Oderda, Diana Brixner, et al.Journal of Managed Care & Specialty Pharmacy|November 2, 2021
The impact of biosimilar insulins on the diabetes landscapeJentora White, Afton Wagner, Hima PatelJournal of Managed Care & Specialty Pharmacy|July 25, 2022
The impact of opioid prescribing report cards in MedicaidMolly Candon, Lingshu Xue, Siyuan Shen, et al.Journal of Managed Care & Specialty Pharmacy|July 25, 2022
Health care resource utilization and costs associated with treatment among patients initiating calcitonin gene-related peptide inhibitors vs other preventive migraine treatments in the United StatesOralee J Varnado, Janna Manjelievskaia, Wenyu Ye, et al.Journal of Managed Care & Specialty Pharmacy|March 28, 2022
Bleeding in patients with hemophilia who have inhibitors: Modeling US medical system utilization and cost avoidance between recombinant factor VIIa products with different clinical dosing requirementsW Allan Alexander, Ivar Jensen, Joanne Hathway, et al.Journal of Managed Care & Specialty Pharmacy|October 4, 2014
Medical cost offsets from prescription drug utilization among Medicare beneficiariesM Christopher RoebuckJournal of Managed Care & Specialty Pharmacy|October 4, 2014
An early examination of access to select orphan drugs treating rare diseases in health insurance exchange plansSandy W Robinson, Kelly Brantley, Christine Liow, et al.Pageof 185